Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE000A1MMCC8
Mon, 06.05.2024
Medios AG
Medios AG: Constantijn van Rietschoten appointed Executive Board member for International Markets
Berlin, May 6, 2024 – The Supervisory Board of Medios AG ("Medios") has appointed Constantijn van Rietschoten as member to the Company's Executive Board with effect from May 1, 2024. In his new role as Chief International Markets, van Rietschoten, who [ … ]
Wed, 27.03.2024
Medios AG
Press release
Medios achieves double-digit growth in 2023 – Positive outlook for 2024
Berlin, March 27, 2024 - Medios AG ("Medios"), the leading provider of specialty pharma solutions in Germany, once again grew strongly in the 2023 financial year. From January to December 2023, consolidated revenue increased by 10.8% to around €1.8 billion (prev [ … ]
Mon, 18.03.2024
Medios AG
Medios acquires Dutch market leader in pharmaceutical compounding servicesImportant first step in building the leading European Specialty Pharma platform – Mid-term targets to be reached already in 2025
Berlin, March 18, 2024 – Medios, the leading provider of Specialty Pharma Solutions in Germany, today announced the acquisition of Ceban Pharmaceu [ … ]
Mon, 18.03.2024
Medios AG
Medios acquires Dutch market leader in pharmaceutical compounding services
Berlin, March 18, 2024 – Medios AG (“Medios”), the leading provider of Specialty Pharma Solutions in Germany, acquires Ceban Pharmaceuticals B.V. ("Ceban"), a fast-growing pharmaceutical compounding platform operating in the Netherlands, Belgium and Spain. With the combinat [ … ]
Thu, 01.02.2024
Medios AG
Press Release
Medios AG: Supervisory Board extends contracts with members of the Executive Board Mi-Young Miehler and Christoph Prußeit
Berlin, February 1, 2024 – The Supervisory Board of Medios AG ("Medios") has decided to extend the existing Executive Board contracts of Mi-Young Miehler (Chief Operating Officer / COO) and Christoph Prußeit (Chi [ … ]
Tue, 14.11.2023
Medios AG
Press release
Medios records strongest quarter in the Company's history
Financials Q3 2023 vs. Q3 2022:
Revenue increases by 16.9% to €489.9 million
EBITDA pre1 increases by 12.7% to €17.2 million
Forecast for the full year 2023 specified
Berlin, November 14, 2023 – Medios, the leading provider of Specialty Pharma Solutions in Germany, once ag [ … ]
Tue, 24.10.2023
Medios AG
Press release
Medios AG: Strong operating cash flow – record figures as expected also for revenue and earnings in the third quarter of 2023
Financials Q3 2023 vs. Q3 2022:
Revenue up 16.9% to €489.9 million
EBITDA pre1 up 12.2% to €17.2 million
Berlin, October 24, 2023 – Medios AG ("Medios"), the leading provider of Specialty Pharma Solutions i [ … ]
Mon, 14.08.2023
Medios AG
Press release
Medios AG achieves further growth in the first half of 2023 and expects strong third quarter
Revenue growth of around 8% with increases in both operating business segments
Strong third quarter of 2023 expected
Forecast for 2023 confirmed: Sustained revenue and earnings growth
Berlin, August 14, 2023 – Medios AG ("Medios"), the lea [ … ]
Wed, 21.06.2023
Medios AG
Press release
Medios AG: Annual General Meeting re-elects Dr. Yann Samson, Joachim Messner and Klaus J. Buß to the Supervisory Board
Berlin, June 21, 2023 – The shareholders of Medios AG ("Medios"), the leading provider of Specialty Pharma Solutions in Germany, have approved the resolutions proposed by the Executive Board and the Supervisory [ … ]
Wed, 21.06.2023
Medios AG
Press release
Medios AG: Annual General Meeting re-elects Dr. Yann Samson, Joachim Messner and Klaus J. Buß to the Supervisory Board
Berlin, June 21, 2023 – The shareholders of Medios AG ("Medios"), the leading provider of Specialty Pharma Solutions in Germany, have approved the resolutions proposed by the Executive Board and the Supervisory [ … ]